Ascendis Pharma
ASND
ASND
202 hedge funds and large institutions have $8.28B invested in Ascendis Pharma in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 67 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.19% less ownership
Funds ownership: 105.35% → 105.16% (-0.19%)
10% less capital invested
Capital invested by funds: $9.19B → $8.28B (-$914M)
52% less call options, than puts
Call options by funds: $21.1M | Put options by funds: $43.9M
Holders
202
Holding in Top 10
17
Calls
$21.1M
Puts
$43.9M
Top Buyers
| 1 | +$121M | |
| 2 | +$83.3M | |
| 3 | +$82.6M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$58.9M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$31.4M |
Top Sellers
| 1 | -$346M | |
| 2 | -$188M | |
| 3 | -$28M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$18.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.1M |